Malcolm Stacey of ShareProphets – Feedback and the Big Spanish Connection
Hello Share Thrashers. It’s not my custom to return to promising shares I’ve brought to your attention in the recent past. I normally wait at least six months or so – with only a few exceptions. But the story is growing fast for one bio science company that I’ve featured quite recently – Feedback (FDBK). […]
Feedback PLC – NHS England “Alert” on potential application of TexRAD for assessing lung cancer patients
Feedback plc is pleased to announce that the research arm of NHS England has published an “Alert” on the potential application of Feedback’s TexRAD CT texture analysis software for assessing patients with lung cancer. The National Institute for Health Research through its Horizon Scanning Research and Intelligence Centre (NIHR HSRIC) based at the University of […]
Feedback PLC forms JV with Quibim SL to develop Prostate Checker TexRAD application
Feedback plc is pleased to announce the incorporation of a 50:50 joint venture company, Prostate Checker Ltd, with QUIBIM S.L., to develop a specific application of TexRAD texture analysis in combination with multiple extracted parameters from MR images for the computer assisted detection and diagnosis of prostate cancer. To facilitate this, Feedback Plc has granted […]
Alan Green discusses Feedback (FDBK) on TipTV
Alan Green discusses Feedback (FDBK) with Nick ‘Moose’ Batsford on TipTV. Click to view.
Feedback PLC – Dr Balaji Ganeshan talks to DirectorsTalk about Stone Checker JV.
Dr Balaji Ganeshan, Chief Scientific Officer at Feedback (FDBK) talks to DirectorsTalk about a new JV with UKUA forming the company “Stone Checker Software Ltd”.
Feedback PLC announces it has licensed TexRAD to Stone Checker
Feedback plc (FDBK), the medical imaging software company, previously announced on 13 April 2015 that it had signed a research agreement with the Oxford Stone Group at the University of Oxford & Oxford University Hospital NHS Trust, UK to investigate the potential future clinical application of Feedback’s TexRAD texture analysis software on computed tomography (CT) […]
More Feedback please! Alan Green discusses Feedback (FDBK) developments on the ADVFN podcast
More Feedback please! Alan Green discusses Feedback (FDBK) developments with Justin Waite on the ADVFN podcast. FDBK assessment is 9 minutes in. Listen to the podcast here
Feedback (FDBK) – First sale of TexRAD in China
Feedback plc (FDBK), the medical imaging software company, is pleased to announce the first sale for research purposes of Feedback’s TexRAD texture analysis software in China. Peking Union Medical College Hospital, Beijing, China (‘PUMCH’), has recently purchased the TexRAD software to undertake research studies in cancer and other diseases. This has been made possible via […]
Feedback PLC (FDBK) – Total voting rights
Feedback plc announces in accordance with the FCA’s Disclosure and Transparency Rules that the issued share capital of the Company comprises 203,673,857 ordinary shares. Shareholders should use 203,673,857 as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, […]
Feedback PLC (FDBK) – Study update
Feedback plc (FDBK), the medical imaging software company, is pleased to announce the successful completion of a large evaluation of TexRAD CT texture analysis (CTTA) as a pre-therapy imaging biomarker in 241 metastatic renal (kidney) cell cancer (m-RCC) patients treated with anti-angiogenic therapy (AAT – drugs that block cancer blood-vessel growth). This research study was […]